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Abstract 
In the human body there are many microorganisms with a variable genetic content. These 
microorganisms play an important role in the metabolism, homeostasis, immune system and generally 
human health. Over the millions of years, different microorganisms adapted to each other, and different 
environmental communities formed on Earth. Microbial communities, known as microbiome, could 
exist in living or non-living environments, such as human body and plants, as well as in soil, oceans, 
and air. The main purpose of microbiome engineering is mostly human microbiome and is now used in 
the treatment of diseases such as Clostridium difficile infection, inflammatory bowel disease, obesity, 
etc. The research data in this thesis were collected from the main medical article sources including Web 
of science, Google scholar, PubMed and Scopus. Articles on microbiome which published during 2010-
2019 were reviewed. The widespread impacts of the microbiome on the ecosystems and the increased 
attention to microbiome recognition are factors contributing to the creation of microbiome engineering 
science, and recent advances in genome sequencing and metagenomic science have made microbiome 
analysis apart from cultivation process. Microbiome engineering has advantages and disadvantages. 
So, according to the positive aspects and efforts to increase applications, this science could lead to 
advances in microbial engineering, and have positive effects on human health. Although microbiome 
engineering is a new field, there has been lots of progressions in recent years that can be an important 
strategy for improving human health by microbial manipulation leading to the changing of microbial 
population. 
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1.  Introduction 
There are many microorganisms in the human 
body with a wide variety of genetic content. These 
microbes play an important role in metabolism, 
homeostasis, immune system, and human health. 
However, most microbes cannot be cultured in a 
laboratory environment except for a limited number of 
bacteria [1]. The mankind has almost the same genetic 
patterns; just a little difference in DNA lead to 
phenotypic diversity among the human population, 
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but the human microbiome metagenomic, which is, 
the whole genome of microbes living in the body, is 
completely variable and unique. Therefore, 
understanding the diversity of healthy microbiome is a 
major challenge in microbiome research and dates 
back to the 1960s and continues through the Human 
Microbiome Project [2, 3]. The Human Microbiome 
Project is a project launched by the National Institute 
of Health (NIH) to identify and analysis of all types of 
microorganisms in the human and the term 
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“Microbiome” was used first time by  Joshua 
Lederberg in 2001 [4, 5]. Through evolution; over 
millions of years, different organisms have adapted to 
each other, and different environmental communities 
have formed on Earth. Microbial communities, known 
as microbiome, can exist in living or non-living 
environments such as the human body, animals, and 
plants, as well as in soil, oceans, and air. The 
microorganisms that make up microbiome are 
actively compatible with the hosts and interactions 
affect on characteristics of the ecosystems in which 
they live. It can also have a wide range of effects on 
physiology (host or environmental conditions). 
Therefore, the widespread impact of the microbiome 
on the ecosystem and increased attention to 
microbiome recognition are factors affecting the 
development of microbial engineering. Recent 
advancements in the sequencing of genome and 
metagenomic science have made it possible to analyze 
microbiome independent of culture techniques [6]. 
The term “Microbiome” refers to all microorganisms 
[including Archaea, bacteria, eukaryotes, and viruses], 
genomes and their environmental conditions, and the 
term “bio” it is an environmental community it has a 
special climate, plants and animals where they live. In 
other words, a microbiome is a combination of 
metagenomic, metabonomic, metatranscriptomic, 
and metaproteomic that is described along with 
comprehensive environmental or clinical information. 
Metagenomic, metabonomic, metatranscriptomic and 
metaproteomic are sciences that have been formed 
around the axis of microbiome engineering. 
Microorganisms in the environment are called 
microbiota. The term microbiota was first coined by 
Lederberg and McCray; human microbiota is made up 
of many microorganisms, including microbes on the 
surface of the skin, genital tract, and gastrointestinal 
tract [6]. The microbiome is a complex term that is 
sometimes mistakenly used instead of microbiota but, 
they have different meanings. The term metagenomic 
is used to describe the sequence of microbial DNA; 
nowadays, the 16SrRNA marker is used. More than 
1,000 intestinal bacterial species have already been 
discovered; Bacteroides have previously been the 
most common intestinal bacteria, classified into five 
genera: Alistipes, Prevotella, Paraprevotella, 
Parabacteroides, and Odoribacter. Metataxonomics 
is the science that describes the whole microbiota and 
their phylogenetic relationships through the analysis 
of their genome. The term microblome is an analytical 
method in which the metabolic profile of a microbiota 
is estimated and described. Metatranscriptomics 
analyzes transcriptional mRNAs, and metaproteomics 
addresses the characteristics of all microbiota proteins, 
first developed by Rodrigue-vaiera [7, 8]. Microbiome 
engineering it tries to shape the microbiota to change 
ecosystems, the characteristics of ecosystems are 
determined by the main microbiome. The unique 
feature of each microbiome is the result of the 
interaction of microorganisms and host communities, 
as well as the response to metabolites produced by 
microbial communities. Therefore, Disruption of 
microbiomes can cause extensive changes in the host 
and the environment, the main goal of microbiome 
engineering is the more human microbiome and today 
it is used in the treatment of diseases. The human 
microbiome project to a large extent advanced 
metagenomic microbial properties in the human 
body, it describes the intestines, mouth, skin, lungs, 
nose, and urinary system. The information obtained 
from the Human Microbiome Project has made 
microbial engineering dramatically provide solutions 
to restore the microbial balance with therapeutic 
functions [2, 6].  
 
2. Methods 
In the present study, related articles were collected 
from main sources such as Web of Science, Google 
scholar, PubMed, and Scopus. The selected articles 
were published between 2010 and 2019, due to the 
remarkable progress that microbiome engineering has 
made during this period. Microbiome engineering has 
reached its peak in the coming years and has a very 
bright future ahead. 
 
3. Discussion 
3.1 Fecal microbiota transplantation 
Jang Lee et al. after receiving healthy feces from a 
healthy donor, prepared a suspension and injected it 
into the gastrointestinal tract of the recipient. They 
reported fecal microbiota transplantation (FMT) or 
fecal transplantation was performed to heeling 
Clostridium difficile infection and restoring the gut 
microbiome; It is also reported to be effective in 
treating Inflammatory Bowel Disease (IBD), diarrhea, 
food poisoning, or other gastrointestinal diseases such 
as rheumatoid arthritis, autism, cancer, weight loss 
and even person's mood and behavior [6, 9-11]. 
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3.2 Reduce muscle pain and probiotic 
Scheiman et al. by study on the gut microbiome 
reported that Veillonella atypica has an important role 
to convert the acetic acid to propionate [12]. Lactic acid 
is caused by prolonged exercise and causes muscle 
pain, while propionate is used by cells to improve 
exercise ability. The study has shown that V. atypica 
can increase running time in marathon runners [12]. 
Yatsonko et al. noted the effects of the microbiome in 
infants. Over time, as a result of contact with the 
environment, more bacteria enter the baby's body, and 
the organisms entering to the body in the first days of 
life will most likely remain for the rest of life. 
Depending on the type of delivery and nutrition 
condition, the microbiome may be different. The study 
noted that the type of delivery affects on baby's 
immune system. Natural delivery leads to stronger 
immune system development in babies [2]. Jernberg 
et al. assessed the role of antibiotics and probiotics in 
association with human microbiome. This study states 
that antibiotics are the most effective agents on 
intestinal homeostasis. Probiotics are usually a 
combination of bacteria that produce lactic acid, such 
as lactobacilli, Bifidobacteria, which are important for 
an appropriate health level [1]. 
 
3.3 Stress and depression 
Nofeld et al. experimented on female mice to show 
the absence of normal microbiota could lead to 
increased anxiety behaviors. Bilateral communication 
between the gastrointestinal tract and the brain is 
important for maintaining intestinal homeostasis. 
This connection is made by the central nervous 
system. Disruption of these systems can lead to 
changes in response to stress and general behaviors. 
The results declared that normal microbiota reduces 
anxiety [13, 14]. Serotonin is known as a 
neurotransmitter that affects the feeling of happiness 
and regulates mood. In fact, more than 90% of the 
serotonin produced is in the gut [15]. O'mahoni et al. 
declared a relation between the intestinal microbiome 
and the synthesis of serotonin and its effect on 
depression. They noted that the intestinal microbiome 
could be a factor in regulating intestinal serotonin 
production. Many intestinal bacteria can produce 
small molecules such as serotonin, epinephrine, and 
norepinephrine. Clostridium sporogenes can produce 
tryptophan, stimulating the production of serotonin. 
Escherichia coli and other bacteria such as enterococci 
can produce serotonin and epinephrine. These 
hormones regulate many of the functions of the 
nervous system in the brain by producing other 
hormones affecting anxiety and stress [3, 15-17]. The 
study mentioned intestinal microbial disorders, 
impaired intestinal serotonin synthesis, leading to 
depression [3, 15-17]. Microbiome engineering with a 
specific metabolic network makes it possible to 
produce specific products; so, the metabolic activities 
of each microbiome leads to a special type of biological 
product with unique properties.  
 
3.4 Future and limitations of microbiome 
engineering  
Microbiome engineering can produce or detect 
intelligent microbes that have new and unique 
properties, which can be used to treat some diseases 
[6]. For example in experiments FMT have been used 
to treat many diseases, including C. difficile, to restore 
the gut microbiome [6]. Additionally, some bacteria 
can be generated which selectively could potentially 
use to eradicate strains of dangerous microbiota in the 
body. For example E. coli has been engineered to 
interrupt signaling between microbes as a means of 
altering the microbiota [18]. Despite extensive 
research on the human microbiome, understanding of 
the microbiota ecosystem is still limited and the 
dynamics of the microbiome and the interactions 
between microbes are not well understood [4, 6]. 
 
4. Conclusions 
Although microbiome engineering passes several 
developments in recent years, it still needs lots of 
researches and studies. Studies on human 
microbiomes which have been performed using 
metagenomic, highlight the undeniable functional role 
of microbiome in the body, and it provides new clinical 
therapeutic methods related to the microbiome. 
Microbiome engineering is an important strategy for 
improving human [6]. 
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